Levels of CD39 expression and activity in regulatory and effector cell subsets govern immunohomeostasis; alterations of CD39 might therefore impact Treg and effector cell functionality and, ultimately, disease outcomes like in Crohn's disease and AIH. Here, ENTPD1 is linked to Crohn disease.